Your browser doesn't support javascript.
loading
Impact of sinus rhythm maintenance on major adverse cardiac and cerebrovascular events after catheter ablation of atrial fibrillation: insights from AF frontier ablation registry.
Usuda, Keisuke; Kato, Takeshi; Tsuda, Toyonobu; Tada, Hayato; Niwa, Satoru; Usui, Soichiro; Sakata, Kenji; Hayashi, Kenshi; Furusho, Hiroshi; Kawashiri, Masaaki; Takamura, Masayuki; Otsuka, Takayuki; Suzuki, Shinya; Hirata, Akio; Murakami, Masato; Takami, Mitsuru; Kimura, Masaomi; Fukaya, Hidehira; Nakahara, Shiro; Shimizu, Wataru; Iwasaki, Yu-Ki; Hayashi, Hiroshi; Harada, Tomoo; Nakajima, Ikutaro; Okumura, Ken; Koyama, Junjiroh; Tokuda, Michifumi; Yamane, Teiichi; Momiyama, Yukihiko; Tanimoto, Kojiro; Soejima, Kyoko; Nonoguchi, Noriko; Ejima, Koichiro; Hagiwara, Nobuhisa; Harada, Masahide; Sonoda, Kazumasa; Inoue, Masaru; Kumagai, Koji; Hayashi, Hidemori; Satomi, Kazuhiro; Yazaki, Yoshinao; Watari, Yuji; Arai, Masaru; Watanabe, Ryuta; Yokoyama, Katsuaki; Matsumoto, Naoya; Nagashima, Koichi; Okumura, Yasuo.
Affiliation
  • Usuda K; Department of Cardiovascular Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.
  • Kato T; Department of Cardiovascular Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan. takeshikato@me.com.
  • Tsuda T; Department of Cardiovascular Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.
  • Tada H; Department of Cardiovascular Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.
  • Niwa S; Department of Cardiovascular Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.
  • Usui S; Department of Cardiovascular Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.
  • Sakata K; Department of Cardiovascular Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.
  • Hayashi K; Department of Cardiovascular Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.
  • Furusho H; Department of Cardiovascular Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.
  • Kawashiri M; Department of Cardiovascular Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.
  • Takamura M; Department of Cardiovascular Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.
  • Otsuka T; Department of Cardiology, The Cardiovascular Institute, Tokyo, Japan.
  • Suzuki S; Department of Cardiology, The Cardiovascular Institute, Tokyo, Japan.
  • Hirata A; Cardiovascular Division, Osaka Police Hospital, Osaka, Japan.
  • Murakami M; Divison of Cardiology, Shonan-Kamakura General Hospital, Kanagawa, Japan.
  • Takami M; Saiseikai Nakatsu Hospital, Osaka, Japan.
  • Kimura M; Divison of Cardiology, Pulmonary Medicine and Nephrology, Hirosaki University School of Medicine, Aomori, Japan.
  • Fukaya H; Kitasato University Hospital, Kanagawa, Japan.
  • Nakahara S; Dokkyo Medical University Saitama Medical Center, Saitama, Japan.
  • Shimizu W; Nippon Medical Hospital, Tokyo, Japan.
  • Iwasaki YK; Nippon Medical Hospital, Tokyo, Japan.
  • Hayashi H; Nippon Medical Hospital, Tokyo, Japan.
  • Harada T; St. Marianna University School of Medicine Hospital, Kanagawa, Japan.
  • Nakajima I; St. Marianna University School of Medicine Hospital, Kanagawa, Japan.
  • Okumura K; Saiseikai Kumamoto Hospital, Kumamoto, Japan.
  • Koyama J; Saiseikai Kumamoto Hospital, Kumamoto, Japan.
  • Tokuda M; Tokyo Jikei University School of Medicine Hospital, Tokyo, Japan.
  • Yamane T; Tokyo Jikei University School of Medicine Hospital, Tokyo, Japan.
  • Momiyama Y; National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
  • Tanimoto K; National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
  • Soejima K; Kyorin University Hospital, Tokyo, Japan.
  • Nonoguchi N; Kyorin University Hospital, Tokyo, Japan.
  • Ejima K; Tokyo Women's Medical University Hospital, Tokyo, Japan.
  • Hagiwara N; Tokyo Women's Medical University Hospital, Tokyo, Japan.
  • Harada M; Fujita University Health Hospital, Aichi, Japan.
  • Sonoda K; Tokyo Rinkai Hospital, Tokyo, Japan.
  • Inoue M; Ishikawa Prefectural Central Hospital, Ishikawa, Japan.
  • Kumagai K; Gunma Cardiovascular Center, Gunma, Japan.
  • Hayashi H; Juntendo University, Tokyo, Japan.
  • Satomi K; Tokyo Medical University Hospital, Tokyo, Japan.
  • Yazaki Y; Tokyo Medical University Hospital, Tokyo, Japan.
  • Watari Y; Teikyo University, Tokyo, Japan.
  • Arai M; Division of Cardiology, Nihon University Itabashi Hospital, Tokyo, Japan.
  • Watanabe R; Division of Cardiology, Nihon University Itabashi Hospital, Tokyo, Japan.
  • Yokoyama K; Department of Cardiology, Nihon University Hospital, Tokyo, Japan.
  • Matsumoto N; Department of Cardiology, Nihon University Hospital, Tokyo, Japan.
  • Nagashima K; Division of Cardiology, Nihon University Itabashi Hospital, Tokyo, Japan.
  • Okumura Y; Division of Cardiology, Nihon University Itabashi Hospital, Tokyo, Japan.
Heart Vessels ; 37(2): 327-336, 2022 Feb.
Article in En | MEDLINE | ID: mdl-34524497
ABSTRACT
The impact of catheter ablation for atrial fibrillation (AF) on cardiovascular events and mortality is controversial. We investigated the impact of sinus rhythm maintenance on major adverse cardiac and cerebrovascular events after AF ablation from a Japanese multicenter cohort of AF ablation. We investigated 3326 consecutive patients (25.8% female, mean age 63.3 ± 10.3 years) who underwent catheter ablation for AF from the atrial fibrillation registry to follow the long-term outcomes and use of anti coagulants after ablation (AF frontier ablation registry). The primary endpoint was a composite of stroke, transient ischemic attack, cardiovascular events, and all-cause death. During a mean follow-up of 24.0 months, 2339 (70.3%) patients were free from AF after catheter ablation, and the primary composite endpoint occurred in 144 (4.3%) patients. The AF nonrecurrence group had a significantly lower incidence of the primary endpoint (1.8 per 100 person-years) compared with the AF recurrence group (3.0 per 100 person-years, p = 0.003). The multivariate analysis revealed that freedom from AF (hazard ratio 0.61, 95% confidence interval 0.44-0.86, p = 0.005) was independently associated with the incidence of the composite event. In the multicenter cohort of AF ablation, sinus rhythm maintenance after catheter ablation was independently associated with lower rates of major adverse cardiac and cerebrovascular events.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Catheter Ablation / Stroke Type of study: Clinical_trials / Etiology_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Heart Vessels Journal subject: CARDIOLOGIA Year: 2022 Document type: Article Affiliation country: Japón

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Catheter Ablation / Stroke Type of study: Clinical_trials / Etiology_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Heart Vessels Journal subject: CARDIOLOGIA Year: 2022 Document type: Article Affiliation country: Japón